Literature DB >> 2153931

Neurologic crises in hereditary tyrosinemia.

G Mitchell1, J Larochelle, M Lambert, J Michaud, A Grenier, H Ogier, M Gauthier, J Lacroix, M Vanasse, A Larbrisseau.   

Abstract

Hereditary tyrosinemia results from an inborn error in the final step of tyrosine metabolism. The disease is known to cause acute and chronic liver failure, renal Fanconi's syndrome, and hepatocellular carcinoma. Neurologic manifestations have been reported but not emphasized as a common problem. In this paper, we describe neurologic crises that occurred among children identified as having tyrosinemia on neonatal screening since 1970. Of the 48 children with tyrosinemia, 20 (42 percent) had neurologic crises that began at a mean age of one year and led to 104 hospital admissions. These abrupt episodes of peripheral neuropathy were characterized by severe pain with extensor hypertonia (in 75 percent), vomiting or paralytic ileus (69 percent), muscle weakness (29 percent), and self-mutilation (8 percent). Eight children required mechanical ventilation because of paralysis, and 14 of the 20 children have died. Between crises, most survivors regained normal function. We found no reliable biochemical marker for the crises (those we evaluated included blood levels of tyrosine, succinylacetone, and hepatic aminotransferases). Urinary excretion of delta-aminolevulinic acid, a neurotoxic intermediate of porphyrin biosynthesis, was elevated during crises but also during the asymptomatic periods. Electrophysiologic studies in seven patients and neuromuscular biopsies in three patients showed axonal degeneration and secondary demyelination. We conclude that episodes of acute, severe peripheral neuropathy are common in hereditary tyrosinemia and resemble the crises of the neuropathic porphyrias.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153931     DOI: 10.1056/NEJM199002153220704

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  48 in total

1.  Hereditary tyrosinemia type 1 from a single center in Egypt: clinical study of 22 cases.

Authors:  Hanaa El-Karaksy; Mona Fahmy; Mona El-Raziky; Nehal El-Koofy; Rokaya El-Sayed; Mohamed S Rashed; Hasan El-Kiki; Ahmad El-Hennawy; Nabil Mohsen
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  Type I hereditary tyrosinaemia: presentation of 11 cases.

Authors:  T Coşkun; I Ozalp; N Koçak; A Yüce; M Caglar; R Berger
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

3.  Abnormal social behavior in mice with tyrosinemia type I is associated with an increase of myelin in the cerebral cortex.

Authors:  Marissa E Moore; Ashton E Koenig; Megan A Hillgartner; Christopher C Otap; Elizabeth Barnby; Gordon G MacGregor
Journal:  Metab Brain Dis       Date:  2017-07-15       Impact factor: 3.584

4.  Liver transplantation for hereditary tyrosinemia: the Quebec experience.

Authors:  K Paradis; A Weber; E G Seidman; J Larochelle; L Garel; C Lenaerts; C C Roy
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

5.  Tyrosinemia type I and not treatment with NTBC causes slower learning and altered behavior in mice.

Authors:  Megan A Hillgartner; Sarah B Coker; Ashton E Koenig; Marissa E Moore; Elizabeth Barnby; Gordon G MacGregor
Journal:  J Inherit Metab Dis       Date:  2016-06-06       Impact factor: 4.982

6.  Alkaptonuria: leading to the treasure in exceptions.

Authors:  Timothy M Cox
Journal:  JIMD Rep       Date:  2011-12-06

7.  Pyruvate dehydrogenase-e1α deficiency presenting as recurrent demyelination: an unusual presentation and a novel mutation.

Authors:  Pratibha Singhi; Linda De Meirleir; Willy Lissens; Sunit Singhi; Arushi Gahlot Saini
Journal:  JIMD Rep       Date:  2013-02-12

Review 8.  Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione).

Authors:  E Holme; S Lindstedt
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

Review 9.  Peripheral neuropathy and inborn errors of metabolism in adults.

Authors:  F Sedel; C Barnerias; O Dubourg; I Desguerres; O Lyon-Caen; Jean-Marie Saudubray
Journal:  J Inherit Metab Dis       Date:  2007-09-21       Impact factor: 4.982

10.  The heme precursor delta-aminolevulinate blocks peripheral myelin formation.

Authors:  Natalia Felitsyn; Colin McLeod; Albert L Shroads; Peter W Stacpoole; Lucia Notterpek
Journal:  J Neurochem       Date:  2008-07-04       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.